You are here

CML

Novartis gets FDA okay for frontline use of Scemblix in CML

Pharmaphorum

Wed, 10/30/24 - 11:38 am

BMS’ long-standing leukemia blockbuster stares down its first generic

Pharma Voice

Fri, 07/12/24 - 11:10 am

Bristol Myers Squibb

Takeda circles leukemia rival to Novartis' Scemblix in up to $1.3B deal with Ascentage

Fierce Pharma

Fri, 06/14/24 - 11:40 am

Ascentage Pharma

Novartis study points to larger role for targeted leukemia drug

BioPharma Dive

Fri, 05/31/24 - 10:50 am

clinical trials

Novartis brings augmented reality tech to ASCO to simulate leukemia patient experience

Fierce Pharma

Thu, 05/30/24 - 11:32 am

augmented reality

Novartis’ Scemblix meets primary endpoints in Phase III leukemia trial

Clinical Trials Arena

Mon, 01/8/24 - 11:41 am

clinical trials

Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug

CP WIre

Thu, 10/20/22 - 12:21 pm

Medicines Patent Pool

Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug

Thu, 10/20/22 - 12:27 pm

Medicines Patent Pool

ASCO: Novartis eyes full nod for Gleevec follow-on Scemblix thanks to new leukemia data

Fierce Pharma

Fri, 05/27/22 - 10:21 am

chronic myeloid leukemia

FDA Approves Scemblix for Pretreated CML in the Chronic Phase

Cure Today

Sat, 10/30/21 - 10:46 pm

ASH20: Out to shake up CML once again, Novartis lays out head-to-head between third-gen Gleevec scion and Pfizer rival

Endpoints

Tue, 12/8/20 - 11:08 pm

ASH: Takeda pads case for new leukemia use with 5-year survival data

Fierce Pharma

Tue, 12/8/20 - 12:11 am

Xspray Pharma reports positive clinical data for HyNap-Dasa product candidate

Pharmaceutical Business Review

Mon, 09/10/18 - 09:30 am

clinical trials

chronic myeloid leukemia

Pfizer's blood cancer drug Bosulif effective in untreated patients

Yahoo/Reuters

Mon, 12/5/16 - 10:06 am

chronic myeloid leukemia

2 Pharmas That Should Move After 55th ASH Meeting

Seeking Alpha

Wed, 11/20/13 - 11:01 am

Ariad Pharmaceuticals

Ariad Pharmaceuticals Plummets 70% as Drug Trial Held

Barron's

Wed, 10/9/13 - 04:00 pm

Ariad Pharmaceuticals

Ariad's Cancer Drug Iclusig Extends The Gleevec Magic

Seeking Alpha

Wed, 05/22/13 - 04:42 pm

Ariad Pharmaceuticals

chronic myeloid leukemia

2 Biotech Companies With Strong Product Launches To Monitor

Seeking Alpha

Tue, 05/14/13 - 05:29 pm

ulcerative colitis

Ariad Pharmaceuticals

chronic myeloid leukemia

Does Ariad's Leukemia Drug Have Hidden Potential?

Motley Fool

Wed, 05/8/13 - 09:11 am

Ariad Pharmaceuticals

chronic myeloid leukemia

Doctors blast ethics of $100,000 cancer drugs

CNN Money

Fri, 04/26/13 - 10:34 am

Pages